Objective: To understand the genotype and distribution of thalassemia in northern Guangxi.

Methods: The study subjects were 55,281 individuals who came to the Affiliated Hospital of Guilin Medical University for genetic diagnosis of thalassemia from January 2012 to August 2023. All of their household registration was in the precincts of Guibei District and its affiliated counties. Red blood cell parameters and hemoglobin analysis were used for thalassemia screening. Gap-PCR, PCR-reverse dot blot hybridization (PCR-RDB), and multicolor melting curve analysis (MMCA) were used to identify common thalassemia genes. Multiplex ligation-dependent probe amplification (MLPA), Sanger sequencing, and third-generation single-molecule real-time (SMRT) sequencing were employed to identify rare thalassemia genes.

Results: Among the 55,281 samples, 16,442 (29.74%) were diagnosed with thalassemia. The detection rates of α, β, and α combined β-thalassemia were 18.57%, 9.99% and 1.18%, respectively. Among ethnical groups, allele mutation frequency of thalassemia was the highest in Zhuang (44.97%), followed by Yao (40.11%), Dong (31.33%), Han (29.85%), Miao (24.31%), and Hui (20.6%). A total of 11,659 alleles (21.09%) of 8 types of α-thalassemia were identified in 55,281 samples, primarily -- (53.9%), followed by -α (21.3%), including rare alleles: -- (0.45%) and HKαα (0.38%). A total of 6367 (11.52%) and 14 types of β-thalassemia alleles were identified, mainly CD41-42 (50.12%), followed by CD17 (22.22%), including rare alleles: β (0.16%) and Gγ (Aγδβ)/β (0.05%). A total of 31 genotypes were detected in 10,264 cases of α-thalassemia, and the main types were --/αα (53.23%), -α/αα (19.15%), and -α/αα (7.21%). A total of 34 genotypes were detected in 5525 cases of β-thalassemia, and the main types were β/β (50.53%), β/β (21.77%), and β/β (12.16%). A total of 78 gene types were detected in 653 cases of α- and β-thalassemia, and the main types were --/αα, β/β (18.68%) and -α/αα, β/β (13.02%). There were 580 cases (5.65%) of HbH disease (α/α), and 4 cases of Hemoglobin Bart's Hydrops Foetus syndrome (--/--). In addition, there were 92 cases (1.67%) of intermedia or severe types of β-thalassemia (β/β, β/β, β/β), including 23 cases of combined α-thalassemia. Among the samples screened negative for thalassemia, 3.7% of them were found to carry thalassemia genes, and 91.35% of the genotypes were αα/αα, -α/αα, and -α/αα. In addition, 40.26% of αα/αα, 22.89% of -α/αα, and 18.51% of -α/αα had no hematological phenotype.

Conclusion: The population in northern Guangxi exhibited rich ethnic diversity, with high allelic carrying rates among the Zhuang, Yao and Dong ethnic groups. Thalassemia gene mutations are diverse, encompassing a variety of gene types, with α thalassemia predominating, notably the --/αα gene type. The prevalence of intermedia or severe types of thalassemia is not low, but there are still some carriers of thalassemia in people who are initially tested negative.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10839378PMC
http://dx.doi.org/10.62347/CQDH5278DOI Listing

Publication Analysis

Top Keywords

thalassemia
14
main types
12
types
9
cases
8
thalassemia northern
8
northern guangxi
8
thalassemia genes
8
55281 samples
8
including rare
8
rare alleles
8

Similar Publications

Efficient repair of human genetic defect by CRISPR/Cas9-mediated interlocus gene conversion.

Life Med

October 2023

Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China.

DNA double-strand breaks (DSBs) induced by gene-editing tools are primarily repaired through non-homologous end joining (NHEJ) or homology-directed repair (HDR) using synthetic DNA templates. However, error-prone NHEJ may result in unexpected indels at the targeted site. For most genetic disorders, precise HDR correction using exogenous homologous sequence is ideal.

View Article and Find Full Text PDF

Waking up the silenced beauty: CRISPR/Cas9 mediated reactivation of fetal hemoglobin genes to treat severe beta-thalassemia in young patients.

Life Med

April 2023

Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, East China Normal University, Shanghai 200241, China.

View Article and Find Full Text PDF

The evolution of genetic exploration tools, from laborious methods like radiationinduced mutations to the transformative CRISPR-Cas9 system, has fundamentally reshaped genetic research and gene editing capabilities. This journey, initiated by foundational techniques such as ZFNs and TALENs and culminating in the groundbreaking work of Doudna and Charpentier in 2012, has ushered in an era of precise DNA alteration and profound insights into gene functions. The CRISPR/Cas9 system uses the Cas9 enzyme and guides RNA (gRNA) to precisely target and cleave DNA, with subsequent repair via error-prone NHEJ or precise HDR, enabling versatile gene editing.

View Article and Find Full Text PDF

Contradictory results for the association between metformin intake and changes in cognitive function have been reported. We attempted to overview systematic reviews and meta-analyses showing the role of metformin, as mono or combination therapy, in cognitive performance alterations among patients with type 2 diabetes mellitus (T2DM) and to determine the quality of the evidence as well. To find the English-written reviews, a literature search was conducted on PubMed, Web of Science, Scopus, Cochrane Library, Trip, and Google Scholar by May 1, 2023.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!